Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Spine (Phila Pa 1976). 2010 Apr 1;35(7):829-34. doi: 10.1097/BRS.0b013e3181b8d9f2.
Prospective, randomized, double blind, clinical study.
To compare the hemostatic and electrolyte effects of 2 commonly administered hydroxyethyl starches (HES) in patients undergoing posterior lumbar interbody fusion (PLIF).
HES are commonly administered colloid solutions to restore and maintain intravascular volume before transfusion is initiated. However, infusion of HES itself can impair coagulation. HES-induced coagulopathy could be a serious problem in PLIF which involves continuous bone bleeding and oozing. Voluven (Fresenius Kabi, Germany), previously regarded as the least coagulopathic due to its low molecular weight (MW) and degree of substitution (DS), is a saline-based HES. Hextend (Biotime, United States) is a new type of HES with physiologic pH and balanced electrolytes, including calcium, which is beneficial to coagulation. Studies comparing the coagulopathy of Hextend and Voluven are rare. Therefore, coagulation, pH/electrolyte changes, and blood loss using Hextend and Voluven in patients undergoing PLIF were compared. METHODS.: Fifty-four patients scheduled for PLIF involving 3 vertebrae or less were randomly assigned to the Voluven or the Hextend group. Of each solution 15 mL/kg was administered during surgery. Blood loss, coagulation, and electrolyte profiles were checked before infusion and 5 minutes, 3 hours, and 24 hours after the end of infusion.
The Hextend group showed slightly better electrolyte balance, however, more coagulation impairment and postoperative transfusion (37% vs. 11%) compared with the Voluven group. The effect of Hextend on coagulation lasted until 24 hours after infusion.
If coagulopathy is a concern during PLIF, then, a HES with low MW/DS in a saline-based medium (Voluven) may be a better alternative than a HES with high MW/DS in a balanced salt medium (Hextend).
前瞻性、随机、双盲、临床研究。
比较两种常用羟乙基淀粉(HES)在接受后路腰椎体间融合术(PLIF)的患者中的止血和电解质效果。
在开始输血前,HES 通常作为胶体溶液用于恢复和维持血管内容量。然而,HES 的输注本身可能会损害凝血功能。HES 诱导的凝血功能障碍可能是 PLIF 中的一个严重问题,因为它涉及持续的骨出血和渗血。Voluven(德国费森尤斯卡比),由于其低分子量(MW)和取代度(DS),之前被认为是最不易引起凝血功能障碍的,是一种基于盐水的 HES。Hextend(美国百特)是一种新型的 HES,具有生理 pH 值和平衡的电解质,包括钙,这有利于凝血。比较 Hextend 和 Voluven 凝血功能障碍的研究很少。因此,比较了 Hextend 和 Voluven 在接受 PLIF 的患者中的凝血、pH/电解质变化和失血量。方法:54 例计划接受 3 个或以下椎体的 PLIF 的患者被随机分配到 Voluven 或 Hextend 组。在手术期间,每组分别给予 15 毫升/公斤的溶液。在输注前、输注结束后 5 分钟、3 小时和 24 小时检查失血量、凝血和电解质谱。
与 Voluven 组相比,Hextend 组的电解质平衡略好,但凝血功能障碍和术后输血(37%比 11%)更多。Hextend 对凝血的影响持续到输注后 24 小时。
如果在 PLIF 期间凝血功能障碍是一个问题,那么,在平衡盐溶液中具有低 MW/DS 的 HES(Voluven)可能是在平衡盐溶液中具有高 MW/DS 的 HES(Hextend)的更好选择。